» Articles » PMID: 31683603

HOXA9 Transcriptionally Promotes Apoptosis and Represses Autophagy by Targeting NF-κB in Cutaneous Squamous Cell Carcinoma

Overview
Journal Cells
Publisher MDPI
Date 2019 Nov 6
PMID 31683603
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Tumor suppressor HOXA9 has been identified to promote apoptosis in cutaneous squamous cell carcinoma (cSCC). However, the mechanism of such pro-apoptotic role of HOXA9 remains obscure. KEGG (Kyoto Encyclopedia of Genes and Genomes) analysis of RNA-seq data showed that NF-κB, apoptosis and autophagy pathways are significantly regulated after HOXA9 knockdown. HOXA9 transcriptionally regulates RELA, the p65 subunit of NF-κB. Loss of HOXA9 in cSCC significantly upregulates RELA expression and thus enhances NF-κB pathway. Interestingly, RELA transcriptionally promotes not only anti-apoptotic factor BCL-XL but also autophagic genes including ATG1, ATG3, and ATG12. Our results reveal an enhanced NF-κB signaling network regulated by HOXA9, which contributes to repressed apoptosis and activated autophagy in cSCC development and may represent an intervention target for cSCC therapy.

Citing Articles

A new potential strategy for cutaneous squamous cell carcinoma treatment by generating serum-based antibodies from tumor-exposed mice.

Liu Z Elife. 2024; 13.

PMID: 39405093 PMC: 11479585. DOI: 10.7554/eLife.95678.


Pan-cancer exploration of oncogenic and clinical impacts revealed that HOXA9 is a diagnostic indicator of tumorigenesis.

Shenoy U, Basavarajappa D, Kabekkodu S, Radhakrishnan R Clin Exp Med. 2024; 24(1):134.

PMID: 38904676 PMC: 11192824. DOI: 10.1007/s10238-024-01389-x.


HOXA9 versus HOXB9; particular focus on their controversial role in tumor pathogenesis.

Hjazi A, Jasim S, Al-Dhalimy A, Bansal P, Kaur H, Qasim M J Appl Genet. 2024; 65(3):473-492.

PMID: 38753266 DOI: 10.1007/s13353-024-00868-x.


Targeting autophagy with natural products as a potential therapeutic approach for diabetic microangiopathy.

Liu F, Zhao L, Wu T, Yu W, Li J, Wang W Front Pharmacol. 2024; 15:1364616.

PMID: 38659578 PMC: 11039818. DOI: 10.3389/fphar.2024.1364616.


HOXA9 gene inhibits proliferation and differentiation and promotes apoptosis of bovine preadipocytes.

He L, Feng X, Hu C, Liu S, Sheng H, Cai B BMC Genomics. 2024; 25(1):358.

PMID: 38605318 PMC: 11007997. DOI: 10.1186/s12864-024-10231-3.


References
1.
Zhou L, Wang Y, Zhou M, Zhang Y, Wang P, Li X . HOXA9 inhibits HIF-1α-mediated glycolysis through interacting with CRIP2 to repress cutaneous squamous cell carcinoma development. Nat Commun. 2018; 9(1):1480. PMC: 5902613. DOI: 10.1038/s41467-018-03914-5. View

2.
Smith L, Yeung J, Zeisig B, Popov N, Huijbers I, Barnes J . Functional crosstalk between Bmi1 and MLL/Hoxa9 axis in establishment of normal hematopoietic and leukemic stem cells. Cell Stem Cell. 2011; 8(6):649-62. DOI: 10.1016/j.stem.2011.05.004. View

3.
Lee E, Fairlie W . The Structural Biology of Bcl-x. Int J Mol Sci. 2019; 20(9). PMC: 6540150. DOI: 10.3390/ijms20092234. View

4.
Chao D, Korsmeyer S . BCL-2 family: regulators of cell death. Annu Rev Immunol. 1998; 16:395-419. DOI: 10.1146/annurev.immunol.16.1.395. View

5.
Klionsky D, Abdelmohsen K, Abe A, Abedin M, Abeliovich H, Arozena A . Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 2016; 12(1):1-222. PMC: 4835977. DOI: 10.1080/15548627.2015.1100356. View